Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Type 2 von Willebrand disease (VWD) impairs platelet function through defective von Willebrand factor (VWF).
• Diagnosis often involves comparing VWF activity (ristocetin cofactor, collagen-binding) to VWF antigen levels.
• VWF multimer analysis, particularly high molecular weight multimers, aids in classification, though their presence/absence varies by subtype.

Purpose of the Study:

• To elucidate the molecular basis of Type 2 VWD subtypes.
• To correlate specific VWF gene mutations with VWF structure-function defects.
• To enhance understanding of VWF biosynthesis and multimerization processes.

Main Methods:

• Analysis of mutations within specific domains of the von Willebrand factor gene.
• Correlation of identified mutations with clinical VWD subtypes (2A, 2B, 2M, Vicenza variant).
• Investigation of VWF structure-function relationships, including multimerization and platelet binding.

Main Results:

• Mutations in the D2 domain are linked to Type 2A (formerly IIC) VWD, affecting multimerization.
• D3 domain mutations characterize the Vicenza variant (formerly IIE).
• A1 domain mutations alter VWF-platelet interactions (increasing affinity in 2B, decreasing in 2M/2A-2M).
• A2 domain mutations in Type 2A VWD cause folding defects or increased proteolysis.
• C-terminus mutations are found in a rare Type 2A subtype (formerly IID).

Conclusions:

• Identification of specific VWF gene mutations is crucial for accurate classification of Type 2 VWD.
• Molecular insights into VWF domains provide a deeper understanding of VWD pathogenesis.
• This knowledge aids in diagnosing and potentially managing VWD subtypes.